載入...
Dramatic response to alectinib in a patient of ALK-rearranged lung cancer with poor performance status
BACKGROUND: Lung cancers with anaplastic lymphoma kinase rearrangements are highly sensitive to anaplastic lymphoma kinase tyrosine kinase inhibition, underscoring the notion that such cancers are addicted to anaplastic lymphoma kinase activity. Several anaplastic lymphoma kinase inhibitors have bee...
Na minha lista:
| 發表在: | BMC Res Notes |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4794901/ https://ncbi.nlm.nih.gov/pubmed/26987388 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-016-1983-9 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|